Objetivo
Epilepsy is a devastating condition affecting over 50 million people worldwide. This multidisciplinary project is focused on the process leading to epilepsy, epileptogenesis, in adults. Our main hypothesis is that there are combinations of various causes, acting in parallel and/or in succession, that lead to epileptogenesis and development of seizures. Our central premise and vision is that a combinatorial approach is necessary to identify appropriate biomarkers and develop effective antiepileptogenic therapeutics. The project will focus on identifying novel biomarkers and their combinations for epileptogenesis after potentially epileptogenic brain insults in clinically relevant animal models, such as traumatic brain injury (TBI) and status epilepticus (SE); explore multiple basic mechanisms of epileptogenesis and their mutual interactions related to cell degeneration, circuit reorganization, inflammatory processes, free radical formation, altered neurogenesis, BBB dysfunction, genetic and epigenetic alterations; and translating these findings towards the clinic by validating biomarkers identified from animal models in human post TBI brain tissue and blood samples, post-mortem brain tissue in individuals that died soon after SE, and human brain and blood samples from chronic epilepsy cases. The project will identify novel combinatorial biomarkers and novel disease-modifying combinatorial treatment strategies for epileptogenesis, create an Epilepsy Preclinical Biobank, and validate translational potential of results from animal models in human tissue. To adequately address the proposed goals, the project will develop technological breakthroughs, such as completely novel chemogenetic approaches, novel MRI techniques, novel multimodal organic recording devices for simultaneous recordings of EEG / cellular unit activity and biochemical measurements, novel bioluminescence for in vivo promoter activity analysis, and novel systems biology approaches.
Ámbito científico
Convocatoria de propuestas
FP7-HEALTH-2013-INNOVATION-1
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-IP - Large-scale integrating projectCoordinador
22100 Lund
Suecia
Ver en el mapa
Participantes (19)
53127 Bonn
Ver en el mapa
La participación finalizó
13120 GARDANNE
Ver en el mapa
70211 KUOPIO
Ver en el mapa
20156 Milano
Ver en el mapa
30559 Hannover
Ver en el mapa
WC1E 6BT London
Ver en el mapa
53127 Bonn
Ver en el mapa
02 093 Warszawa
Ver en el mapa
13284 Marseille
Ver en el mapa
SW7 2AZ LONDON
Ver en el mapa
44121 Ferrara
Ver en el mapa
1105AZ Amsterdam
Ver en el mapa
84105 Beer Sheva
Ver en el mapa
La participación finalizó
80333 Muenchen
Ver en el mapa
La participación finalizó
69680 CHASSIEU
Ver en el mapa
30625 Hannover
Ver en el mapa
La participación finalizó
2333 CH LEIDEN
Ver en el mapa
N20 9YZ LONDON
Ver en el mapa
75008 Paris
Ver en el mapa